BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28541476)

  • 1. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
    García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
    Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.
    Jiang M; Peng Q; Liu X; Jin J; Hou Z; Zhang J; Mori S; Ross CA; Ye K; Duan W
    Hum Mol Genet; 2013 Jun; 22(12):2462-70. PubMed ID: 23446639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.
    Tsai T; Klausmeyer A; Conrad R; Gottschling C; Leo M; Faissner A; Wiese S
    Mol Cell Neurosci; 2013 Sep; 56():18-28. PubMed ID: 23500004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.
    Ahmed S; Kwatra M; Gawali B; Panda SR; Naidu VGM
    Apoptosis; 2021 Feb; 26(1-2):52-70. PubMed ID: 33226552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
    Simmons DA; Belichenko NP; Yang T; Condon C; Monbureau M; Shamloo M; Jing D; Massa SM; Longo FM
    J Neurosci; 2013 Nov; 33(48):18712-27. PubMed ID: 24285878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia.
    Yang YJ; Li YK; Wang W; Wan JG; Yu B; Wang MZ; Hu B
    Pharmacol Biochem Behav; 2014 Jul; 122():30-6. PubMed ID: 24662915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging.
    Zeng Y; Liu Y; Wu M; Liu J; Hu Q
    J Alzheimers Dis; 2012; 31(4):765-78. PubMed ID: 22710915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation.
    Zhao J; Du J; Pan Y; Chen T; Zhao L; Zhu Y; Chen Y; Zheng Y; Liu Y; Sun L; Hang P; Du Z
    Free Radic Biol Med; 2019 Jan; 130():557-567. PubMed ID: 30472367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.
    Todd D; Gowers I; Dowler SJ; Wall MD; McAllister G; Fischer DF; Dijkstra S; Fratantoni SA; van de Bospoort R; Veenman-Koepke J; Flynn G; Arjomand J; Dominguez C; Munoz-Sanjuan I; Wityak J; Bard JA
    PLoS One; 2014; 9(2):e87923. PubMed ID: 24503862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.
    Agrawal R; Noble E; Tyagi E; Zhuang Y; Ying Z; Gomez-Pinilla F
    Biochim Biophys Acta; 2015 May; 1852(5):862-72. PubMed ID: 25661191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor.
    Liu X; Obianyo O; Chan CB; Huang J; Xue S; Yang JJ; Zeng F; Goodman M; Ye K
    J Biol Chem; 2014 Oct; 289(40):27571-84. PubMed ID: 25143381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early 7,8-Dihydroxyflavone Administration Ameliorates Synaptic and Behavioral Deficits in the Young FXS Animal Model by Acting on BDNF-TrkB Pathway.
    Chen YS; Zhang SM; Tan W; Zhu Q; Yue CX; Xiang P; Li JQ; Wei Z; Zeng Y
    Mol Neurobiol; 2023 May; 60(5):2539-2552. PubMed ID: 36680734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.